CN106267408A - A kind of full-automatic Regional Citrate Anticoagulation device - Google Patents
A kind of full-automatic Regional Citrate Anticoagulation device Download PDFInfo
- Publication number
- CN106267408A CN106267408A CN201510310217.7A CN201510310217A CN106267408A CN 106267408 A CN106267408 A CN 106267408A CN 201510310217 A CN201510310217 A CN 201510310217A CN 106267408 A CN106267408 A CN 106267408A
- Authority
- CN
- China
- Prior art keywords
- citric acid
- calcium
- mmol
- peristaltic pump
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3672—Means preventing coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
- A61M1/3644—Mode of operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
- A61M1/3661—Cannulae pertaining to extracorporeal circulation for haemodialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3626—Gas bubble detectors
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- External Artificial Organs (AREA)
Abstract
The invention discloses a kind of full-automatic Regional Citrate Anticoagulation device, controller connects the first peristaltic pump, the second peristaltic pump and I/O control module respectively, I/O control module is connected with bubble detection module and alarm module respectively, described controller transmission of control signals is for controlling the first peristaltic pump and the feed liquor speed of the second peristaltic pump, the detection signal of bubble detection module is transferred to controller by described I/O control module, and described I/O control module controls the opening and closing of alarm module.Alleviate the work load of medical personnel to a certain extent, improve safety simultaneously.Carry the anticoagulation that the invention enables Regional Citrate Anticoagulation to become a kind of simplicity, promote it in clinical application.
Description
Technical field
The present invention relates to a kind of automaton, in particular a kind of full-automatic Regional Citrate Anticoagulation device.
Background technology
External anticoagulant is the key that blood purification is smoothed out.Regional Citrate Anticoagulation (regional citrate
Anticoagulation, RCA) definite because having anticoagulant effect, the advantages such as hemorrhage complication is few, dialyser prolongation in service life,
Become the ideal chose of current highly accomplished cardiopulmonary bypass in patients anticoagulant.But, due to potential Metabolic complication, operation
Complex, period needs the problems such as frequent monitoring, limits it in clinical application.
As it is shown in figure 1, traditional Regional Citrate Anticoagulation technology is to circulate arterial end in vitro, according to blood flow rate with a definite proportion
Example infusion liquor sodii citratis, replenishes the calcium at vein end (before blood returns in the patient) simultaneously, thus ensure in the patient from
Sub-calcium level is normal.Regional Citrate Anticoagulation-CRRT principle: citric acid is from arterial end infusion, the ion in extracorporeal circulation pipeline
Calcium level is down to 0.2-0.4mM/L, plays anticoagulation effect in vitro, supplements calcium from vein end simultaneously, and internal ionized calcium level maintains
Normally, and internal blood coagulation system is not affected.R (replacement): displacement liquid;UF (ultrafiltrate): ultrafiltrate.
In Fig. 1,4% sodium citrate inputs from vein end, makes extracorporeal circulation ionized calcium be down to 0.2-0.4mmol/L, reaches anticoagulant
Effect, supplements calcium chloride from vein end simultaneously, makes internal ionized calcium level recover to 1.0-1.2mmol/L.
According to the experience in existing document report and real work, generally there is following asking in clinical application in traditional RCA
Topic:
(1) need extra two precision transfusion pumps of increase on the basis of original apparatus for purifying blood molten for citric acid soln and calcium
The infusion of liquid, complex operation;
(2) citric acid infusion pump and infusion pump of replenishing the calcium are two independent pumps, when treatment Parameters variation or dialysis machine because reporting to the police,
Change the reason tremulous pulse pump terminations of pumping such as displacement liquid/dialysis solution, it is necessary to dialysis nurse manually suspends/start the two pump, if operation is not
Specification, too much or hypercalcemia causes extracorporeal circulation anticoagulant failure to be likely to result in iatrogenic citric acid infusion;
(3) traditional citrate anticoagulation scheme mainly uses " trial-and-error method " of monitoring-adjustment-monitor again, the most first sets
A fixed speed of initially replenishing the calcium, then internal by frequently monitoring and extracorporeal circulation ionized calcium level adjusts speed of replenishing the calcium.We are saturating
Analysis center is initially also adopted by this empirical " trial-and-error method " scheme at application RCA, found that internal ionized calcium level fluctuates relatively
Greatly, and owing to the change of calcium lags behind the adjustment of calcium, it is difficult to the accurate assurance amount of replenishing the calcium;
(4) input during RCA manpower (at least needs one by the hemodialysis nurse of strict training and to be familiar with citrate anticoagulation technology
Doctor on the scene), material resources (needing every 2-4 hour monitoring ionized calcium, every time measure expense 150 yuan) cost puts into huge.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that a kind of full-automatic Regional Citrate Anticoagulation device, it is achieved
Low artificial automatization.
The present invention is achieved by the following technical solutions, and the present invention includes controller, the first peristaltic pump, the second peristaltic pump, I/O
Control module, bubble detection module, alarm module;Described controller connects the first peristaltic pump, the second peristaltic pump and I/O respectively
Control module, I/O control module is connected with bubble detection module and alarm module respectively, and described controller transmission of control signals is used
In controlling the feed liquor speed of the first peristaltic pump and the second peristaltic pump, described I/O control module is by the detection signal of bubble detection module
Being transferred to controller, described I/O control module controls the opening and closing of alarm module.
Described bubble detection module detection process is: by ultrasound examination tube for transfusion, when the reflection coefficient of ultrasound wave is more than setting
Scope, then detect in tube for transfusion have bubble, and the reflection coefficient of ultrasound wave in set point, then detects in tube for transfusion and do not has
Bubble.
Described controller connects the first peristaltic pump, the second peristaltic pump and I/O control module by RS-485 bus respectively.
Described alarm module is the display lamp of three kinds of colors.
Described first peristaltic pump is citric acid pump, and the second peristaltic pump is chlorination calcium pump.
The speed of described first peristaltic pump and the second peristaltic pump is denoted as Qcit and Q respectivelyCaCl2, the second corresponding peristaltic pump QCaCl2Control
Process includes replenish the calcium first stage and second stage of replenishing the calcium, and within after anticoagulant starts three hour, enters second stage of replenishing the calcium,
The infusion velocity of the first peristaltic pump Qcit is obtained by formula:
Qcit=Qb × (1-Hct) × C0mmol/Csolution;
Wherein, Qcit: unit interval citric acid infusion velocity ml/h,
Qb: blood flow rate ml/min,
Hct: packed cell volume %,
Csolution:1L citric acid soln contains amount mmol of citric acid,
C0: 3~5mmol/L;
In described first stage 0~3 hours, the amount of replenishing the calcium per hour:
QCaCl2=Qca/0.34
Described second stage is after 3 hours, the amount of replenishing the calcium per hour:
Or:
Qca (phaseII)=Qeffluent × Cca_effluent
QCaCl2=Qca/0.34
Wherein, calcium amount mmol/h that Qca: the unit interval should supplement,
Qcacl2: unit interval 5% calcium chloride solution infusion velocity ml/h,
Qca (phase I): the first stage unit time amount of replenishing the calcium mmol/h,
Qca (phase II): the second stage unit interval amount of replenishing the calcium mmol/h,
CcaT (art): the total calcium concentration of arterial end, is equivalent to internal total calcium concentration mmol/L,
Qpw: blood plasma water speed L/h,
Quf: ultrafiltrate speed L/h,
Qsub: displacement liquid speed L/h,
WT: body weight kg,
Css (t): internal citric acid Css mmol/L,
Csys: internal citric acid blood drug level mmol/L
Qeffluent: effluent speed L/h,
Cca_effluent: effluent total calcium concentration mmol/L.
Described internal citric acid blood drug level:
Wherein, G: the citric acid flow mmol/h in unit interval tube for transfusion,
C (0): basis citric acid concentration mmol/L,
CLb: body clearance rate L/h to citric acid,
CLf: dialyser clearance rate L/h to citric acid,
T: citric acid Infusion Time h,
V: internal citric acid apparent volume of distribution L.
Citric acid flow in described unit interval tube for transfusion:
G=Qp × Cinf × (1-Ecit),
Cinf: every liter blood plasma adds citric acid amount mmol/L,
Ecit: citric acid filtration fraction,
Qp: plasmaflux L/h.
According to internal citric acid, calcium principle of dynamics, speed of replenishing the calcium in RCA-CRRT therapeutic process can reach according to internal citric acid
The Css time is divided into two benches.Kramer etc. report without citric acid half-life average out to 36 points in liver cirrhosis critical patient body
Clock, according to pharmacokinetic theory, vivo medicine concentration reaches Css after 5 half-life, the most internal citric acid concentration
Within three hours after RCA-CRRT starts, reach Css, RCA-CRRT is started after the 3rd hour as replenish the calcium speed adjustment time
Between point.(Kramer L, Bauer E, Joukhadar C, et al.Crit Care Med, 2003,31:2450-2455.)
Css (t) is internal citric acid Css (mmol/L), can be with following citric acid pharmacokinetics mathematical model
(concrete mathematical model is derived and is seen Zheng Yin, Xu Zhongye, Jiao Zheng etc. in prediction.Citric acid medicine generation during continuous renal replacementtherapy
Thank to the structure of dynamics mathematical model.Chinese Journal of Nephrology 2010;26 (6): 432-437. citric acid pharmacokinetics numbers
Modelling verification sees: Yin Zheng, Zhongye Xu, Qiuyu Zhu, Junfeng Liu, Jing Qian, Huaizhou
You,Yong Gu,Chuanming Hao,Zheng Jiao,Feng Ding.Citrate Pharmacokinetics in
Critically Ill Patients with Acute Kidney Injury.PLoS ONE 2013,8 (6): e65992.
(the citric acid pharmacokinetics of critical patients with acute renal failure)
The present invention has the advantage that this device aims at RCA anticoagulant design compared to existing technology, by whole to citric acid pump and pump of replenishing the calcium
Closing, this double pump system can link with dialysis machine tremulous pulse pump again, be simultaneously embedded in citric acid, calcium infusion mathematical model, controlled two
The speed of pump, it is not necessary to medical personnel cross multioperation.Needed monitoring in every 2-4 hour internal during RCA and pipeline ionized calcium in the past,
Within 24 hours, CRRT needs frequently monitoring 6~8 times, and is replenished the calcium by the speed of replenishing the calcium of computed in software, and monitoring interval extends, and 24 is little
Time treatment only need to detect 2~3 times.Alleviate the work load of medical personnel to a certain extent, improve safety simultaneously.Improve
Critical acute injury of kidney patient, especially merges high-risk bleeding risk patient, the salvage success rate of blood purification treatment.The present invention
On the one hand alleviate the labor intensity of staff, on the other hand decrease medical expense.Regional Citrate Anticoagulation is made to become one
Plant easy anticoagulation, promote it in clinical application.
Accompanying drawing explanation
Fig. 1 is the structural representation of prior art;
Fig. 2 is the structural representation of the present invention;
Fig. 3 is the application structure schematic diagram of this enforcement;
Fig. 4 be the present embodiment two benches replenish the calcium model long-time CVVH treat in application effect schematic diagram.
Detailed description of the invention
Elaborating embodiments of the invention below, the present embodiment is implemented under premised on technical solution of the present invention,
Give detailed embodiment and concrete operating process, but protection scope of the present invention is not limited to following embodiment.
As in figure 2 it is shown, the present embodiment includes that controller, the first peristaltic pump, the second peristaltic pump, I/O control module, bubble are examined
Survey module, alarm module;Described controller connects the first peristaltic pump, the second peristaltic pump and I/O control module respectively, and I/O is controlled
Molding block is connected with bubble detection module and alarm module respectively, and described controller transmission of control signals is for controlling the first peristaltic pump
With the feed liquor speed of the second peristaltic pump, the detection signal of bubble detection module is transferred to controller by described I/O control module, institute
State I/O control module and control the opening and closing of alarm module.
Traditional RCA scheme needs by " monitoring-adjust-monitoring " mode adjustment citric acid and the input of calcium, and the present invention is by Chinese holly
Rafter acid infusion mathematical model, two benches mathematical model C# language of replenishing the calcium is written as software, is needed by man-machine dialog interface input
Clinical indices and treatment parameter, by RS485 bus marco citric acid pump and the rotating speed of pump of replenishing the calcium, two pumps just can be according to setting
Fixed rotating speed inputs citric acid and calcium in the extracorporeal circulation pipeline that trend connects.
The software principle that the present invention is applied to is as follows: software uses C# language to write, and Runtime Library is Microsoft.Net
Framework 3.5.Software provides two kinds of modes of operation: automatically control and Non-follow control.
Bubble detection module detection process is: by ultrasound examination tube for transfusion, when the reflection coefficient of ultrasound wave is more than set point,
Then detecting in tube for transfusion have bubble, the reflection coefficient of ultrasound wave in set point, then detects in tube for transfusion do not have bubble.
Described controller connects the first peristaltic pump, the second peristaltic pump and I/O control module by RS-485 bus respectively.
Described alarm module is the display lamp of three kinds of colors.
If there is bubble in tube for transfusion, then bubble detection module will detect this bubble, and by RS485 bus notification controller
Stop the injection of this two pumps.When system runs well, display lamp green light;During pipeline preliminary filling, amber light is bright;In infusion process
Will report to the police when having bubble, display lamp when red, two pumps shut down simultaneously.Bubble detection module uses ultrasound detection bubble former
Reason, i.e. when ultrasound wave is propagated in media as well, runs into the different interface of acoustic impedance and can produce scatter reflections, thus can cause ultrasonic
The decay of ripple.When not having bubble in tube for transfusion, ultrasonic reflection coefficient is the least, almost without decay;When having bubble, due to
The acoustic impedance difference of air and water is relatively big, and ultrasound wave has the biggest reflection coefficient, and now ultrasonic attenuation is serious.When bubble is examined
When survey module is not detected by bubble, export logic level 0;When bubble being detected, export logic level 1.
I/O control module is multi-channel module, carries out data interaction, major control also by RS-485 communication modes and controller
The display lamp of three colors and bubble detection module.Multichannel I/O module can control the open and close of three lamps, also may be used simultaneously
Read the state of bubble detection module, and this state is sent in time to controller.
Described first peristaltic pump is citric acid pump, and the second peristaltic pump is chlorination calcium pump.
In order to be calculated infusion flow, the parameter of needs: total calcium concentration CcaT_art (mmol/L), displacement liquid speed Qsub
(L/h), citric acid infusion velocity Qcit (L/h), ultrafiltrate speed Quf (L/h), blood flow velocity Qb (L/h), erythrocyte
Specific volume Hct, total protein concentration TP (g/L), patient body weight WT (kg).
Citric acid infusion velocity mathematical formulae is as follows:
Qcit=Qb × (1-Hct) × 4mmol/L
Qcit represents citric acid infusion velocity L/h,
Hct: hematocrit value.
Two benches process of replenishing the calcium is as follows:
Citric acid accumulation in body when its core concept is Regional Citrate Anticoagulation, the citric acid of accumulation is mainly deposited with calcium salt forms
, according to citric acid pharmacokinetic parameter, accumulation typically reaches stable state in about 3 hours after treatment starts.Therefore, locally
Replenishing the calcium of citrate anticoagulation is also required to be divided into two stages, and the first stage requires supplementation with body accumulation calcium and calcium is removed in extracorporeal circulation,
Second stage has only to added body outer circulation and removes calcium.It should be noted that the two benches that this device proposes replenish the calcium mathematical model fit
For there is the low elimination efficiency blood purification pattern of citric acid accumulation, such as CRRT etc..And for the blood purification of high elimination efficiency
Pattern (such as conventional Intermittent hemodialysis etc.), is negligible owing to there is not citric acid accumulation or accumulation, can regard as
State the special case of model, be i.e. directly entered second stage and replenish the calcium, without supplementary accumulation calcium part.Equipment under automatic control mode
Possessing and automatically adjust speed function of replenishing the calcium, speed of i.e. replenishing the calcium divides two-part.RCA starts latter 3rd hour, and system can point out entrance
Replenishing the calcium to second stage, relevant parameter can be carried out resetting with flow velocity.Once arrange successfully, system can automatically according to
Second stage parameter directly changes the exploitation speed of two pumps, it is not necessary to doctor's troublesome operation.Simultaneity factor arranges Autonomous test with parameter
Function, after i.e. input arranges parameter, system will arrange parameter the most rationally by automatic decision, if unreasonable it would appear that prompting is believed
Breath, prevents doctor from inputting the maloperation in parametric procedure.
As it is shown on figure 3, as a example by continuous venovenous hemofiltration (CVVH) illustrate, in figure 1~9 be respectively formula 1~
9。
Eq1: unit of account time blood plasma discharge Qpw (L/h):
Eq1:Qpw=Qb × (1-Hct) × (1-Cprotein/100)
Qb: blood flow L/h;
Hct: hematocrit %;
Cprotein: total protein concentration of serum g/L.
Eq2: total calcium concentration CcaT_in (mmol/L) before filter after calculating citric acid infusion:
Eq2:
CcaT_art: internal total calcium concentration mmol/L;
Qcit: citric acid infusion velocity L/h;
Qsub: displacement liquid flow L/h.
Eq3: calculating after citric acid infusion before filter can disperse calcium concentration CcaF_in (mmol/L):
Eq3:
Fa: total ca proportion % can be accounted for by disperse calcium.
Eq4: calcium amount Caflux (mmol/h) that calculating extracorporal dialysis is removed:
S: sieve coefficient ≈ 1.
Eq4:Caflux=Quf × S × CcaF_in.
Eq5:Eq3 and Eq4 merges.
Eq5:
Eq6: calculating body accumulation calcium concentration Ca_bound (t) (mmol/L):
Eq6: Δ Cca_bound (t)=fb × Csys (t)
Fb: accumulation calcium concentration and citric acid concentration correlation coefficient;
Csys (t): concentration mmol/L during citric acid point.
Eq7: citric acid Pharmacokinetics Formula:
C (0): basis citric acid concentration mmol/L;
Kf: external citric acid dialysis clearance rate L/h;
Kb: internal citric acid clearance rate L/h;
T: citric acid Infusion Time h;
V: citric acid apparent volume L;
G: the citric acid flow mmol in unit interval tube for transfusion, i.e. the citric acid flow of internal injection in the unit interval.
Eq8: calculating body accumulation calcium total amount Qca (mmol):
Eq8:Qca=fb × Csys (t) × Body Weight × 25%
Body Weight: body weight kg;
25%: extracellular fluid volume.
Eq9: before citric acid reaches stable state, the first stage replenishes the calcium loading Qca1 (mmol):
QCaCl2=Qca/0.34
Css (cit): internal citric acid Css mmol/L.
Fig. 4 be the present embodiment two benches replenish the calcium equipment long-time CVVH treat in application (n=10).CVVH treatment time is equal
It is longer than 24 hours, the data of display to 24 hour.First stage speed of replenishing the calcium is 6.24 ± 0.43mmol/h, second stage
It is reduced to 5.10 ± 0.22mmol/h.In the patient and dialysis pipeline intermediate ion calcium concentration the most smoothly control in the ideal range.
The foregoing is only presently preferred embodiments of the present invention, not in order to limit the present invention, all spirit in the present invention and former
Any amendment, equivalent and the improvement etc. made within then, should be included within the scope of the present invention.
Claims (8)
1. a full-automatic Regional Citrate Anticoagulation device, it is characterised in that include controller, the first peristaltic pump, the second wriggling
Pump, I/O control module, bubble detection module, alarm module;Described controller connects the first peristaltic pump, the second wriggling respectively
Pump and I/O control module, I/O control module is connected with bubble detection module and alarm module respectively, the transmission control of described controller
Signal processed is for controlling the first peristaltic pump and the feed liquor speed of the second peristaltic pump, and described I/O control module is by bubble detection module
Detection signal is transferred to controller, and described I/O control module controls the opening and closing of alarm module.
One the most according to claim 1 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described bubble detects
Module detection process is: by ultrasound examination tube for transfusion, when the reflection coefficient of ultrasound wave is more than set point, then detect defeated
Having bubble in liquid pipe, the reflection coefficient of ultrasound wave in set point, then detects in tube for transfusion do not have bubble.
One the most according to claim 1 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described controller divides
Do not connect the first peristaltic pump, the second peristaltic pump and I/O control module by RS-485 bus.
One the most according to claim 1 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described alarm module
It it is the display lamp of three kinds of colors.
One the most according to claim 1 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described first wriggles
Pump is citric acid pump, and the second peristaltic pump is chlorination calcium pump.
One the most according to claim 5 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described first wriggles
The speed of pump and the second peristaltic pump is denoted as Qcit and Q respectivelyCaCl2, the second corresponding peristaltic pump QCaCl2Control process includes replenishing the calcium first
Stage and second stage of replenishing the calcium, enter second stage of replenishing the calcium in after anticoagulant starts three hour,
The infusion velocity of the first peristaltic pump Qcit is obtained by formula:
Qcit=Qb × (1-Hct) × C0mmol/Csolution;
Wherein, Qcit: unit interval citric acid infusion velocity ml/h,
Qb: blood flow rate ml/min,
Hct: packed cell volume %,
Csolution:1L citric acid soln contains amount mmol of citric acid,
C0: 3~5mmol/L;
In described first stage 0~3 hours, the amount of replenishing the calcium per hour:
QCaCl2=Qca/0.34
Described second stage is after 3 hours, the amount of replenishing the calcium per hour:
Or:
Qca (phaseII)=Qeffluent × Cca_effluent
QCaCl2=Qca/0.34
Wherein, calcium amount mmol/h that Qca: the unit interval should supplement,
Qcacl2: unit interval 5% calcium chloride solution infusion velocity ml/h,
Qca (phase I): the first stage unit time amount of replenishing the calcium mmol/h,
Qca (phase II): the second stage unit interval amount of replenishing the calcium mmol/h,
CcaT (art): the total calcium concentration of arterial end, is equivalent to internal total calcium concentration mmol/L,
Qpw: blood plasma water speed L/h,
Quf: ultrafiltrate speed L/h,
Qsub: displacement liquid speed L/h,
WT: body weight kg,
Css (t): internal citric acid Css mmol/L,
Csys: internal citric acid blood drug level mmol/L,
Qeffluent: effluent speed L/h,
Cca_effluent: effluent total calcium concentration mmol/L.
One the most according to claim 6 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described internal citron
Acidemia concentration:
Wherein, G: the citric acid flow mmol/h in unit interval tube for transfusion,
C (0): basis citric acid concentration mmol/L,
CLb: body clearance rate L/h to citric acid,
CLf: dialyser clearance rate L/h to citric acid,
T: citric acid Infusion Time h,
V: internal citric acid apparent volume of distribution L.
One the most according to claim 7 full-automatic Regional Citrate Anticoagulation device, it is characterised in that described unit interval
Citric acid flow in tube for transfusion:
G=Qp × Cinf × (1-Ecit),
Cinf: every liter blood plasma adds citric acid amount mmol/L,
Ecit: citric acid filtration fraction,
Qp: plasmaflux L/h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510310217.7A CN106267408A (en) | 2015-06-08 | 2015-06-08 | A kind of full-automatic Regional Citrate Anticoagulation device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510310217.7A CN106267408A (en) | 2015-06-08 | 2015-06-08 | A kind of full-automatic Regional Citrate Anticoagulation device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106267408A true CN106267408A (en) | 2017-01-04 |
Family
ID=57659988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510310217.7A Pending CN106267408A (en) | 2015-06-08 | 2015-06-08 | A kind of full-automatic Regional Citrate Anticoagulation device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106267408A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107617132A (en) * | 2017-07-31 | 2018-01-23 | 上海交通大学医学院附属第九人民医院 | Suitable for the citrate anticoagulation control system during CVVHD and its device and its application |
CN112675375A (en) * | 2019-10-18 | 2021-04-20 | 上海市松江区中心医院(上海交通大学附属第一人民医院松江分院) | CRRT machine with high-precision RCA function |
WO2022193488A1 (en) * | 2021-03-17 | 2022-09-22 | 上海溯湃医疗科技有限公司 | Regional citrate anticoagulation infusion system, control method and system, and medium |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0587101A2 (en) * | 1992-09-11 | 1994-03-16 | Fresenius AG | Apparatus for the removal of aluminium ions from blood and solution used in this apparatus |
US5676841A (en) * | 1991-12-23 | 1997-10-14 | Baxter International Inc. | Blood processing systems and methods which monitor citrate return to the donor |
CN102309785A (en) * | 2010-07-05 | 2012-01-11 | 复旦大学附属华山医院 | Method for improving regional citric acid anticoagulation |
CN102716518A (en) * | 2012-06-21 | 2012-10-10 | 重庆山外山科技有限公司 | Blood purification equipment with citrate anticoagulant device |
CN104056315A (en) * | 2014-06-20 | 2014-09-24 | 郭淑玲 | Bubble monitoring system for blood purification |
-
2015
- 2015-06-08 CN CN201510310217.7A patent/CN106267408A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676841A (en) * | 1991-12-23 | 1997-10-14 | Baxter International Inc. | Blood processing systems and methods which monitor citrate return to the donor |
EP0587101A2 (en) * | 1992-09-11 | 1994-03-16 | Fresenius AG | Apparatus for the removal of aluminium ions from blood and solution used in this apparatus |
CN102309785A (en) * | 2010-07-05 | 2012-01-11 | 复旦大学附属华山医院 | Method for improving regional citric acid anticoagulation |
CN102716518A (en) * | 2012-06-21 | 2012-10-10 | 重庆山外山科技有限公司 | Blood purification equipment with citrate anticoagulant device |
CN104056315A (en) * | 2014-06-20 | 2014-09-24 | 郭淑玲 | Bubble monitoring system for blood purification |
Non-Patent Citations (4)
Title |
---|
许钟烨: "连续性肾脏替代治疗时局部枸橼酸抗凝的两阶段补钙数学模型及重症急性肾损伤患者和健康人群枸橼酸药代动力学研究", 《医药卫生科技编辑》 * |
郑寅,丁峰: "局部枸橼酸抗凝在连续性肾脏替代治疗中的应用", 《中国血液净化》 * |
郑寅,许钟烨等: "连续性肾脏替代治疗时枸橼酸药物代谢动力学数学模型的构建", 《中华肾脏病杂志》 * |
郑寅: "连续性肾脏替代疗法时枸橼酸代谢动力学模型的构建及其在局部枸橼酸抗凝CRRT中的应用", 《医药卫生科技辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107617132A (en) * | 2017-07-31 | 2018-01-23 | 上海交通大学医学院附属第九人民医院 | Suitable for the citrate anticoagulation control system during CVVHD and its device and its application |
CN112675375A (en) * | 2019-10-18 | 2021-04-20 | 上海市松江区中心医院(上海交通大学附属第一人民医院松江分院) | CRRT machine with high-precision RCA function |
CN112675375B (en) * | 2019-10-18 | 2022-01-07 | 上海市松江区中心医院(上海交通大学附属第一人民医院松江分院) | CRRT machine with high-precision RCA function |
WO2022193488A1 (en) * | 2021-03-17 | 2022-09-22 | 上海溯湃医疗科技有限公司 | Regional citrate anticoagulation infusion system, control method and system, and medium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5023071B2 (en) | Citrate anticoagulation system for extracorporeal blood treatment | |
US7351218B2 (en) | Device and process for extracorporeal treatment by citrate anticoagulant | |
US7699806B2 (en) | Medical fluid therapy flow balancing and synchronization method and apparatus | |
JP4583486B2 (en) | Automation and optimization of CRRT therapy using local citrate anticoagulant | |
CN105813665A (en) | Device and method for regulating and specifying the pump rate of blood pumps | |
MX2011013606A (en) | Methods of regional citrate anticoagulation dialysis. | |
JP2003512900A (en) | Extracorporeal blood purification device | |
CN107617132B (en) | Citric acid anticoagulation control system suitable for CVVHD process, device and application thereof | |
CN106267408A (en) | A kind of full-automatic Regional Citrate Anticoagulation device | |
US4721564A (en) | Apparatus for the filtration of plasma from blood | |
US20240115788A1 (en) | Regional citrate anticoagulation infusion system, control method and system, and medium | |
CN206518724U (en) | Citrate anticoagulation device | |
CN106573100A (en) | Method for cleaning an extracorporeal blood circuit | |
US11738125B2 (en) | Systems and methods for estimating ultrafiltration rates | |
CN209075635U (en) | Citrate anticoagulation device | |
CN210750527U (en) | System for indirectly monitoring level of extracorporeal circulation ionized calcium | |
CN105536085B (en) | A kind of continous way CRRT machine capability bascules | |
CN110124134A (en) | A kind of ascites ultra-filtration concentration therapeutic equipment | |
CN211301424U (en) | Special blood purification system of children | |
CN111821530B (en) | Method and system for indirectly monitoring level of extracorporeal circulation ionized calcium | |
CN112675375B (en) | CRRT machine with high-precision RCA function | |
CN115826079A (en) | Portable artificial kidney system bubble detection and injection blockage judgment unit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |